Details for Patent: 8,329,216
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,329,216 protect, and when does it expire?
Patent 8,329,216 protects OPANA ER and is included in two NDAs.
This patent has forty-eight patent family members in sixteen countries.
Summary for Patent: 8,329,216
Title: | Oxymorphone controlled release formulations |
Abstract: | The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief. |
Inventor(s): | Kao; Haui-Hung (Syosset, NY), Baichwal; Anand R. (Wappingers Falls, NY), McCall; Troy (Smyrna, GA), Lee; David (Chadds, PA) |
Assignee: | Endo Pharmaceuticals Inc. (Chadds Ford, PA) |
Application Number: | 11/427,438 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,329,216 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Use; Composition; Delivery; |
Drugs Protected by US Patent 8,329,216
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-001 | Jun 22, 2006 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-005 | Feb 29, 2008 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,329,216
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 359077 | See Plans and Pricing | |||
Austria | 376832 | See Plans and Pricing | |||
Australia | 2002316582 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |